appliedbiocode, Author at Applied BioCode

2018 News & Press Release

IDEXX to Introduce Applied BioCode’s Innovative Multiplex Technology Across Global Reference Laboratory Network

01/08/2018

WESTBROOK, Maine –(BUSINESS WIRE)– IDEXX Laboratories, Inc. (NASDAQ: IDXX) and Applied BioCode (6598:Taipei) today announced that they have entered into …

IDEXX to Introduce Applied BioCode’s Innovative Multiplex Technology Across Global Reference Laboratory Network

Applied BioCode Submits 510(k) Application to FDA for BioCode MDx-3000 with Gastrointestinal Pathogen Panel

Applied Biocode to Submit Gastrointestinal Pathogen Panel to FDA in Bid to Displace Luminex

Applied BioCode Completes Beta Sites for Molecular Diagnostic System

Applied BioCode Listed on Taiwan Emerging Market Stock Exchange

Applied BioCode Inks Partnership and Supply Agreement with Diatherix for Multiplex MDx Reference Laboratory Testing

Applied BioCode Awarded Digital Barcode Patent for Identifying Multiplexed Biomarkers or Pathogens

Applied BioCode to Present Poster at AMP on 18-Plex GI Pathogen Panel with a High Throughput System

Applied BioCode Licenses Patents to Molecular Devices.

Applied BioCode to Present Poster at CVS on Multiplex Gastrointestinal Pathogen Detection with a User Friendly, High Throughput Molecular Diagnostic System.

Applied BioCode Expands PerkinElmer Deal for Infectious Disease MDx in Asia.

Applied BioCode to Present Poster at CVS on Multiplex Gastrointestinal Pathogen Detection with a User Friendly, High Throughput System.

Search

Categories